期刊文献+

TFF2在胃癌、癌旁及正常胃黏膜组织中的表达及其与血管生成的关系 被引量:3

Correlation between TFF2 expression and tumor angiogenesis in gastric carcinoma, adjacent carcinoma and normal gastric mucosa
下载PDF
导出
摘要 目的:探讨三叶因子2(TFF2)、血管内皮生长因子(VEGF)和微血管密度(MVD)在胃癌发生、发展、浸润和转移中的作用.方法:选取广西医科大学第一附属医院2008-01/2009-06接受胃大部切除术的胃癌标本50例,采用SP免疫组织化学方法检测30例正常胃黏膜组织、50例癌旁组织和50例胃癌组织中TFF2、VEGF和MVD的表达情况.结果:正常胃黏膜组织→癌旁组织→胃癌组织中,TFF2表达呈逐渐减弱趋势(165.80±16.42,184.44±19.02,206.79±17.62,均P<0.01),TFF2的表达与肿瘤的分化程度和淋巴结转移有关(均P<0.01),而VEGF的表达和MVD值呈逐渐上升趋势(36.7%,42.0%,72.6%;26.35±4.54,30.78±5.64,40.13±6.92,均P<0.01),两者表达与肿瘤的分化程度、浸润深度和淋巴结转移有关(均P<0.01).TFF2与MVD的表达呈负相关(r=-0.781,P<0.01).结论:TFF2作为一种胃癌的抑制因子,在胃癌发展过程中表达逐渐减弱,对胃癌的抑制作用降低,同时一些促进肿瘤浸润转移的因子如VEGF、MVD表达水平逐渐增强,促进了肿瘤的发展转移. AIM: To investigate the correlation among the expression of trefoil factor 2 (TFF2) and vascular endothelial growth factor (VEGF) and microves- sel density (MVD) in gastric carcinoma. METHODS: The expression of TFF2 and VEGF and MVD were determined by immunohisto- chemistry in 50 gastric carcinoma specimens, 50 tumor-adjacent gastric mucosal specimens, and 30 normal gastric mucosa specimens. RESULTS: The expression level of TFF2 was highest in normal gastric mucosa, followed by tumor-adjacent gastric mucosa and gastric carcinoma (165.80 ± 16.42, 184.44 ± 19.02, 206.79 ± 17.62, all P 〈 0.01). The expression of TFF2 in gastric cancer was significantly associated with the degree of tumor differentiation and lymph node metastasis (both P 〈 0.01). The expression level of VEGF and MVD were lowest in normal gastric mucosa, followed by tumor-adjacent gastric mu- cosa and gastric carcinoma (36.7%, 42.0%, 72.6%; 26.35 ± 4.54, 30.78 ± 5.64, 40.13 ± 6.92, all P 〈 0.01). The expression of VEGF and MVD in gastric cancer were associated with tumor differentiation, invasion and lymph node metastasis (all P 〈 0.01). There is a negative correlation between the expression of TFF2 and MVD (r = -0.781, P 〈 0.01). CONCLUSION: TFF2 may be a negative regulatory factor of gastric carcinogenesis. The expression of TFF2 is down-regulated during the development of gastric cancer, while that of VEGF and MVD are up-regulated during this process.
出处 《世界华人消化杂志》 CAS 北大核心 2011年第3期246-250,共5页 World Chinese Journal of Digestology
基金 广西卫生厅自筹经费科研课题基金资助项目 No.Z2008111~~
关键词 三叶因子2 血管内皮生长因子 微血管密度 胃癌 免疫组织化学 Trefoil factor 2 Vascular endothelialgrowth factor Microvessel density Gastric cancer Immunohistochemistry
  • 相关文献

参考文献3

二级参考文献29

  • 1Yu Cheng Tang,Yu Li,Guan Xiang Qian Department of Biochemistry, Shanghai Second Medical University, Shanghai 200025, China.Reduction of tumorigenicity of SMMC-7721 hepatoma cells by vascular endothelial growth factor antisense gene therapy[J].World Journal of Gastroenterology,2001,7(1):22-27. 被引量:33
  • 2Wei Xin Niu,Xin Yu Qin,Han Liu,Cheng Pei Wang Surgical Department, Zhongshan Hospital, Fu Dan University Medical Center, Shanghai 200032, China.Clinicopathological analysis of patients with gastric cancer in 1200 cases[J].World Journal of Gastroenterology,2001,7(2):281-284. 被引量:29
  • 3Chang-Tai Xu~1 Lian-Tian Huang~1 Bo-Rong Pan~2 1 Editorial Department,the Journal of Fourth Military Medical University2 Oncology Center,Xijing Hospital,Fourth Military Medical University,169 Changle Xilu,Xi’an 710032,Shaanxi Province,China.Current gene therapy for stomach carcinoma[J].World Journal of Gastroenterology,2001,7(6):752-759. 被引量:16
  • 4Ichikura T, Tomimatsu S, Ohkura E, Mochizuki H. Prognostic significance of the expression of vascular endothelial growth factor (VEGF) and VEGF-C in gastric carcinoma. J Surg Oncol.2001; 78:132-137.
  • 5Kakeji Y, Koga T, Sumiyoshi Y, Shibahara K, Oda S, Maehara Y, Sugimachi K. Clinical significance of vascular endothelial growth factor expression in gastric cancer. J Exp Clin Cancer Res 2002; 21: 125-129.
  • 6Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P. Cloning of eDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res 1982; 10:7895-7903.
  • 7Luqmani Y, Bennett C, Paterson I, Corbishley CM, Rio MC, Chambon P, Ryall G. Expression of the pS2 gene in normal, benign and neoplastic human stomach. Int J Cancer 1989; 44:806-812.
  • 8Leung WK, Yu J, Chan FK, To KF, Chan MW, Ebert MP, Ng EK, Chung SC, Malfertheiner P, Sung JJ. Expression of trefoil peptides (TFF1, TFF2, and TFE3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues. J Pathol 2002; 197:582-588.
  • 9Park WS, Oh RR, Park JY, Yoo NJ, Lee SH, Shin MS, Kirn SY, Kim YS, Lee JH, Kim HS, An WG, Lee JY. Mapping of a new target region of allelic loss at 21q22 in primary gastric cancers. Cancer Lett 2000; 159:15-21.
  • 10Lefebvre O, Chenard MP, Masson R, Linares J, Dierich A, LeMeur M, Wendling C, Tomasetto C, Chambon P, Rio MC. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 1996; 274:259-262.

共引文献86

同被引文献35

  • 1徐艳红,温宏武.雌激素受体亚型ERα和ERβ在子宫内膜癌中表达的研究[J].中国医刊,2006,41(8):31-33. 被引量:10
  • 2杨宏亮,田珩,李沛波,王永刚,苏薇薇.柚皮苷及柚皮素的生物活性研究[J].中药材,2007,30(6):752-754. 被引量:78
  • 3Susumu A, Yasukazu O. Test for serum Levels of Trefoil Factor Family Proteins Can Improve Gastric Cancer Screening[J]. Gastroero-logy, 2011, 141(3):837-845.
  • 4Rinnert M, Hinz.M, Buhtz P, et al. Synthesis and localization of trefoil factor family (TFF1) peptides in the human urinary tract and TFF2 ex- cretion into the urine[J]. Cell Tissue Res, 2010:339(3):639-647.
  • 5Peterson A J, Menheniott T R, O Connor L. Helicobaeter pylnri infect- ion promotes methylation and silencing of trefoil factor 2, leading to gastric tumor development in mice and 0 humans[J]. Gastroenterology, 2010, 139(6):2005-2017.
  • 6Tu SP, ChiAL, AiW, et al. P53 inhibition ofAPl-dependent TFF2 ex- pression induces apoptosis and inhibits cell migration in gastric cancer cells[J]. Am J Physiol Gastrointest Liver Physiol, 2009, 297(2): 385-396.
  • 7Campbell-Thompson ML. Estrogen Receptor c and [3 Expression in Upper Gastrointestinal Tract with Regulation of Trefoil Factor Fam- ily 2 mRNA Levels in Ovariectomized Rats [J]. Biochemiaal and Bi- ophysical Research Communications,1997, 240(2): 478-483.
  • 8Yarnachika T,Werther J L, Bodian C,ct al. Intestinal trefoil factor:a marker of poor prognosis in gastric carcinoma [J]. Clin Cancer Rcs, 20028(5): 1092-1099.
  • 9Perry JK, Kannan N, Grandison PM, et al. Are trefoiI factors oncogenic?[J]. Trends Endocrinol Metab, 2008, 19:74-81.
  • 10Dhar DK, Wang TC, Maruyama R, et al. Expression of cytoplasmic TFF2 is a marker of tumor metastasis and negative prognosis factor in gastric cancer[J]. Lab Invest, 2003(83):1343-1352.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部